MLYS
Mineralys·NASDAQ
--
--(--)
--
--(--)
MLYS Filings
Filing Date
Form Description
Form Type
2026-03-31
Form 144 - Report of proposed sale of securities
Ownership
2026-03-31 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-31
Form 144 - Report of proposed sale of securities
Ownership
2026-03-31 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-31
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-31 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-17
Form 144 - Report of proposed sale of securities
Ownership
2026-03-17 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-13
Form 144 - Report of proposed sale of securities
Ownership
2026-03-13 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-12
Mineralys Therapeutics, Inc.(MLYS)-20260313-2025 Q4 Earnings call transcript
Earnings Call
2026-03-12 · Earnings Call
Mineralys Therapeutics, Inc.(MLYS)-20260313-2025 Q4 Earnings call transcript
2026-03-12
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-12 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-12
Form 144 - Report of proposed sale of securities
Ownership
2026-03-12 · Ownership
Form 144 - Report of proposed sale of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
